Research
Jan 15, 2023
A Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics, and antiviral activity of combinations of monoclonal antibodies administered via intravenous infusion in healthy, HIV-uninfected adults Web Links:...
Jan 14, 2023
Characterizing SARS-CoV-2-specific immunity in convalescent individuals Clinical Trials
Jan 13, 2023
ICAP conducted this study to develop and follow a cohort of HIV-infected adults starting ART at health facilities across Kenya to understand the levels of inflammatory and coagulation biomarkers in clients and the effect of ART on those...
Jan 6, 2023
This study investigated the experimental microbicide gel tenofovir to protect women against HIV. The study provided information on how much vaginal tenofovir gel, when used in combination with common vaginal products, will interfere with the local and or systemic...
Jan 3, 2023
ICAP is conducting formative research to inform the design and implementation of combination prevention interventions, including pre-exposure prophylaxis (PrEP) for female sex workers, as well as to inform recruitment and retention strategies for female sex workers...